- PRESS RELEASE Dec 10, 2013 Paris: PR-FR.Theranexus, biopharma company, has announced the signing of a license agreement with the CEA and BMSystems to develop patented new therapeutic strategies for use in psychiatry.
- PRESS RELEASE Dec 3, 2013 Paris, Louvain Belgium: BMSystems and Aepodia sign a strategic R&D collaboration to decipher the Fibromyalgia & chronic facial pain mechanisms to bring novel therapeutic strategies to patients.
- PRESS RELEASE: BMSystems and Persistent Systems Launch Strategic Joint Systems Biology R&D Initiative.
The Mechanisms-based Medicine Company that delivers. Download the presentation
BMSystems is the first and, to date the only integrative systems biology company that succeeded to create in-silico non-mathematical heuristic models validated in-vivo.
The discoveries, patented, led to attractive businesses through its innovative dual Research/Business model, in the fields of infectious diseases, neurology, psychiatry, oncology, dermatology, immunology, metabolism & bioprocesses for industrial biotech.
The life-modeling issue
We invented CADI*™
CADI™ is the first and, to date, the only solution that succeeded to create in-vivo validated in-silico heuristic models of complex human pathologies & physiological processes.
Since 2004, BMSystems implements its disruptive collaborative research strategy and its innovative business model to generate scientific and business successes.
*CADI™ : Computer Assisted Deductive Integration